ECO ANIMAL HEALTH GROUP PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 107.5 GBX | +4.88% |
|
+14.36% | -0.92% |
| Apr. 25 | EARNINGS AND TRADING: ECO Animal revenue up; Zephyr starts drilling | AN |
| Apr. 25 | Eco Animal Health Group plc Provides Earnings Guidance for the Year 2024 | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company is in a robust financial situation considering its net cash and margin position.
- The stock, which is currently worth 2024 to 0.61 times its sales, is clearly overvalued in comparison with peers.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company sustains low margins.
- With an expected P/E ratio at 46.48 and 37.33 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -0.92% | 90.71M | C | ||
| -19.73% | 72.39B | B+ | ||
| -11.01% | 6.54B | B- | ||
| +15.88% | 3.43B | B- | ||
| -0.68% | 1.4B | - | ||
| -17.27% | 1.34B | B | ||
| -2.73% | 1.26B | - | ||
| -28.16% | 1.2B | C- | ||
| -14.67% | 1.12B | - | ||
| -5.37% | 990M | - |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- EAH Stock
- Ratings ECO Animal Health Group plc
